Enzymotec Announces It Has Been Granted Patents For INFAT®'S Uses In Canada And The US
2/3/2014 9:03:01 AM
MIGDAL HA'EMEQ, Israel, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it was granted a patent by the Canadian Patent and Trademark Office for the use of INFAT® for the promotion of intestinal development and maturation, and further announced that it was granted a patent by the U.S. Patent and Trademark Office for the use of INFAT® in enhancing infant bone strength.
Help employers find you! Check out all the jobs and post your resume.
comments powered by